Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of ...

The FTC sued pharmacy benefit managers over their roles in increasing insulin prices over the past decade. The News talked to ...

The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

The Centers for Medicare & Medicaid Services Oct. 9 released a request for information and a sample list of prescription ...

Type 1 diabetes (also known as diabetes mellitus) is an autoimmune disease in which immune cells attack and destroy the insulin-producing cells of the pancreas. The loss of insulin leads to the ...

However, the guidance does identify some circumstances where it may be appropriate to prescribe some of the items on the low priority prescribing guidance list. Since the guidance was first published ...

The closer you get to the final stage of diabetes nephropathy, called kidney failure, or end-stage renal disease (ESRD), the more likely you will need specific medications or procedures ... if you are ...